Request Demo
Last update 22 Mar 2025
Atorvastatin calcium/choline fenofibrate
Last update 22 Mar 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Atorvastatin calcium trihydrate/choline fenofibrate, Fenofibrate/atorvastatin, CKD-337 |
Target |
Action inhibitors, agonists |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), PPARα agonists(Peroxisome proliferator-activated receptor α agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC66H76CaF2N4O13 |
InChIKeyHIZONJHAVINWOX-NIJVSVLQSA-N |
CAS Registry344423-98-9 |
View All Structures (2)
Related
4
Clinical Trials associated with Atorvastatin calcium/choline fenofibrateNCT03382756
A Cross-over, Randomized and Open-label Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-337 After a Single Oral Dose in Healthy Male Subjects
NCT03346187
A Randomized, Open-label, Single Oral Dose, 2-way Crossover Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 in Healthy Male Volunteers
KCT0001787
A randomized, open-label, single oral dose, 2-way crossover clinical trial to compare safety and pharmacokinetic characteristics of CKD-337 in healthy male volunteers
100 Clinical Results associated with Atorvastatin calcium/choline fenofibrate
Login to view more data
100 Translational Medicine associated with Atorvastatin calcium/choline fenofibrate
Login to view more data
100 Patents (Medical) associated with Atorvastatin calcium/choline fenofibrate
Login to view more data
100 Deals associated with Atorvastatin calcium/choline fenofibrate
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dyslipidemias | Phase 3 | United States | 01 Oct 2007 | |
| Chronic Kidney Diseases | Phase 1 | - | 01 Jan 2016 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free